IntegriChain Acquires the Life Sciences Division of Cumberland, Creating the Largest Data and Business Process Platform for Market Access and Commercialization of Specialty, Precision, and Retail Pharmaceuticals

Transaction Expands Customer Base to 220+ Life Sciences Manufacturers, including 20 of Top 20, and Team to 350+ 

Philadelphia, PA, April 13, 2020 – IntegriChain, a leading Life Sciences data and managed services company that helps drive access to life-saving and life-changing medicines, today announced that it has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. With this acquisition, IntegriChain delivers the Life Science industry’s most comprehensive and scalable data and business process platform for commercialization and market access of cell and gene therapy, specialty, and retail pharmaceuticals.

“This acquisition reinforces IntegriChain’s market-leading position to help manufacturers drive access and maximize their commercialization success throughout the brand life cycle, from pre-launch through growth,” said IntegriChain Co-Founder and CEO Kevin Leininger. “We now deliver the industry’s first and only data and managed services platform that unifies all of the critical business functions for commercialization and market access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider and pharmacy insights for our customers. As a result of this transaction, we are uniquely positioned to address critical therapy access challenges and ensure patients have access to specialty and precision medicines. We welcome all Cumberland Life Science consultants and professionals to our expanding global team as we continue to partner with our extensive combined customer base of more than 220 life sciences manufacturers to solve their access challenges.”

Read more.

IntegriChain Taps Liaison Technologies Veteran Gary Palgon to Lead Sales Organization

Palgon is a subject matter expert on cloud-based solutions, security/compliance, and big data across healthcare and life sciences and other industry verticals. Prior to joining IntegriChain, he was Vice President of Sales and Marketing at Liaison Technology. At Liaison, he was responsible for rapid sales growth in providing enterprise integration and management of patient and supply chain data as a cloud-based service and drove the company’s M&A and integration initiatives. Previously he served in multiple executive roles at nuBridges, Geac, and several start-up organizations and was responsible for new product and technology introductions in the respective marketplaces. Palgon earned a BS in Computer and Information Sciences at the University of Florida.

With Palgon’s addition to the IntegriChain leadership team, Executive Vice President Josh Halpern will continue to be responsible for Product and Strategy while building out the company’s marketing capabilities and taking on added responsibility for corporate development.

About IntegriChain

IntegriChain is a leading healthcare technology company for bio/pharma manufacturers, uniquely employing world-class data science to integrate disparate sources of commercial data to deliver analytics that help patients start and stay on therapy. US bio/pharma manufacturers partner with us to manage their government and commercial payer contracts, aggregate their specialty and distribution channel data, drive patient access, and streamline critical processes like government pricing and gross-to-net. Today IntegriChain is the trusted partner for all Top-10, 16 of the Top-20, and more than 80 other bio/pharma manufacturers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA; the Access Management Operations center is in Ambler, PA; and the Patient Services Center is in Atlanta, GA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain and LinkedIn.

Center City health tech company acquires MontCo firm following major investment

Written by Michelle Caffrey, Philadelphia Business Journal

Center City heath care tech company IntegriChain announced Tuesday it’s acquired a Fort Washington firm, the first deal the pharma-focused company has made since a Silicon Valley private equity firm bought out all its outsider investors last year.

Financial terms of the acquisition of PharmaMetrics were not disclosed.

In a statement, IntergiChain’s co-founder and CEO Kevin Leininger said the deal will allow the company, which helps life sciences companies manage their operations and data via the cloud, to “bring together disparate commercial data assets into one enrichment and analytics platform.”

It employs about 80, a number that will grow to nearly 110 following the acquisition of PharmaMetrics. Annual bookings are expected to exceed $25 million with the deal.

Click here to read the full article.